Two Anti-Aging Studies Fuel 250-Year Claims And Crypto’s Longevity Bet

What Happened

Crypto fortunes keep flowing into longevity research, and two fresh studies from Asia have given the anti-aging movement new momentum.

Why Crypto Money Backs Longevity Research

Crypto donors helped set the tone for this wave of crypto wealth philanthropy.

Market Context

Longevity has become one of the biggest bets in tech and crypto circles. The global anti-aging market reached roughly $85 billion in 2025. Longevity biotech startups then raised about $3.7 billion in early 2026, up more than 50% from a year earlier.

BeInCrypto’s Future Tech expert council has tracked this shift closely. Its contributors include biologist Aubrey de Grey, who leads the Longevity Escape Velocity Foundation and studies how to slow aging.

Why It Matters

The findings also fed a viral online claim that humans could soon live to 250. That number came from social media, not from the scientists behind the work.

“We demonstrated that this synergistic mechanism could improve age-related muscle weakness in fruit flies and extend their lifespan.”

This is where the 250-year figure entered the story. An Instagram account called elixirofscience shared the research and claimed it could stretch human life to 250 years.

The second study comes from the University of Osaka in Japan. It centers on a protein called AP2A1. The work was published in the journal Cellular Signalling in January 2025.

Details

Ethereum co-founder Vitalik Buterin gave $2.4 million to the anti-aging charity SENS in 2018. He later donated more than $13 million to the Methuselah Foundation, another group chasing longer human lifespans.

Buterin has argued for years that aging is a problem worth attacking directly. His gifts pushed the idea into the wider crypto community. Since then, founders and funds across the industry have joined in.

Venture money followed the philanthropy. Altos Labs, a cellular reprogramming company, raised $3 billion in funding. Younger startups such as Retro Biosciences and NewLimit pulled in nine-figure rounds through 2025.

In total, longevity startups have now attracted more than $13 billion in venture funding.

Many backers share a simple belief. They treat aging as a problem that technology can eventually fix, much like a bug in software. That view fits neatly with crypto culture’s long-term horizons.

Korean Drug That Kept Aging Cells Younger

One study driving the excitement comes from Chung-Ang University in Seoul. Researchers there tested a compound called IU1. Their paper appeared in the journal Autophagy in 2024.

Aging wears down the systems that clear damaged proteins from our cells. When that balance is disrupted, faulty proteins accumulate and stress the cell. Researchers link that buildup to diseases such as Alzheimer’s and Parkinson’s.

IU1 gave two of those cleanup systems a boost simultaneously. In fruit flies, it eased age-related muscle weakness and extended lifespan. Flies age quickly and share many traits with people, which makes them a common test model.

The team reported similar effects in human cells grown in the lab. Lead researcher Seogang Hyun framed the results carefully.

The post spread across X and other platforms. However, no researcher made that claim, and it was flies, not people, that lived longer.

Osaka Discovery That Flips Cells Young Again

Old cells tend to grow large and stop working properly. These worn-out cells build up in the body over time. They are tied to wrinkles, weaker muscles, and many age-related conditions.

The researchers found that AP2A1 helps lock cells in that aged state. When the team lowered the protein levels, the old cells started behaving like young cells again. The same effect was observed across several cell types and triggering mechanisms of aging.

“Suppressing AP2A1 in older cells reversed senescence and promoted cellular rejuvenation, while AP2A1 overexpression in young cells advanced senescence.”